e-learning
resources
European Respiratory Review
2013
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
New perspectives in long-term outcomes in clinical trials of pulmonary arterial hypertension
Preston Ioana R., Suissa Samy, Humbert Marc
Source:
Eur Respir Rev 2013; 22: 495-502
Journal Issue:
December 2013 - 22 (130)
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Preston Ioana R., Suissa Samy, Humbert Marc. New perspectives in long-term outcomes in clinical trials of pulmonary arterial hypertension. Eur Respir Rev 2013; 22: 495-502
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on acute decompensated pulmonary hypertension
ERS statement on chronic thromboembolic pulmonary hypertension
COVID-19 and the pulmonary circulation
Related content which might interest you:
Do we need controlled clinical trials in pulmonary arterial hypertension?
Source: Eur Respir J 2001; 17: 1-3
Year: 2001
Interpreting risk reduction in clinical trials for pulmonary arterial hypertension
Source: Eur Respir Rev, 27 (148) 180020; 10.1183/16000617.0020-2018
Year: 2018
Clinical trial design and new therapies for pulmonary arterial hypertension
Source: Eur Respir J, 53 (1) 1801908; 10.1183/13993003.01908-2018
Year: 2019
Pregnancy outcomes in pulmonary arterial hypertension in the modern management era
Source: Eur Respir J 2012; 40: 1304-1305
Year: 2012
End-points and clinical trial design in pulmonary arterial hypertension: have we made progress?
Source: Eur Respir J 2009; 34: 231-242
Year: 2009
Early improvements predict outcomes in pulmonary arterial hypertension
Source: International Congress 2018 – Risk stratification in treatment of pulmonary arterial hypertension
Year: 2018
Long-term outcomes of dasatinib-induced pulmonary arterial hypertension: a population-based study
Source: Eur Respir J, 50 (1) 1700217; 10.1183/13993003.00217-2017
Year: 2017
Bosentan treatment for pulmonary arterial hypertension related to congenital heart disease: real-world clinical experience in Spain
Source: Annual Congress 2009 - Pulmonary hypertension
Year: 2009
Effect of selexipag on long-term outcomes in key subgroups of patients with pulmonary arterial hypertension (PAH): GRIPHON study results
Source: International Congress 2015 – Pulmonary hypertension: new treatment insights
Year: 2015
Pulmonary rehabilitation in patients with group 3 pulmonary hypertension: evaluation of clinical outcomes, adherence and safety.
Source: International Congress 2019 – The future of pulmonary rehabilitation discussed today
Year: 2019
New horizons in pulmonary arterial hypertension management
Source: Eur Respir Rev 2014; 23: 408-409
Year: 2014
Long-term safety and clinical effects of riociguat in chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension: Interim analysis of a phase II extension study
Source: Annual Congress 2010 - Pulmonary hypertension updates
Year: 2010
Current medical treatment of pulmonary arterial hypertension
Source: School Course 2012 - Pulmonary hypertension and pulmonary vascular disease
Year: 2012
Current medical treatment of pulmonary arterial hypertension
Source: ERS Skills course - Pulmonary hypertension and pulmonary vascular disease
Year: 2018
Current medical treatment of pulmonary arterial hypertension
Source: ERS Course 2017 - Pulmonary Hypertension and Pulmonary Vascular Disease
Year: 2017
Current medical treatment of pulmonary arterial hypertension
Source: School Course 2014 - Pulmonary Hypertension and Pulmonary Vascular Disease
Year: 2014
Identification of treatment goals in paediatric pulmonary arterial hypertension
Source: Eur Respir J 2014; 44: 1616-1626
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept